Is it time to implement HPA-1 screening in pregnancy?

Anne Husebekk1, Mette K Killie, Jens Kjeldsen-Kragh

  • 1University Hospital North Norway, Norway. anne.husebekk@unn.no

Summary

Screening pregnant women for HPA-1 typing can reduce deaths from foetal/neonatal alloimmune thrombocytopenia (FNAIT). A Norwegian study showed screening and intervention are effective and cost-efficient, with antibody levels correlating to newborn severity.